Invizius
PrivateLast Round
VC Round
Sep 23, 2024
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Invizius operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a VC Round in September 2024.
Invizius is a biotechnology company developing a complement-regulating therapy platform designed to mitigate harmful immune responses in extracorporeal medical procedures.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invizius Comparables
Compare Invizius with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoGroup SA | 74% | |
| Evonik Industries AG | 68% | |
| Fresenius Medical Care | 64% |
For institutional investors. Book with your work email.
Invizius Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 23, 2024 | ||||
| Grant | Mar 30, 2022 | ||||
| Series A | May 6, 2021 | ||||
| Pre Seed | Oct 22, 2019 | ||||
| Seed | Apr 30, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Invizius Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Mercia Ventures | VC Round |
| Old College Capital | Series A, Pre Seed, Seed, VC Round |
| Downing Ventures | Series A, Pre Seed |
| Calculus Capital | Series A, VC Round |
| Scottish National Investment Bank | Pre Seed |
| Mercia Asset Management | Series A, Pre Seed, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 453% MoM.
- Jul 27, 2026
Monthly visitors grew 207% MoM, reaching 295.
For institutional investors. Book with your work email.
Invizius Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Invizius's valuation, stock price, and market status.
Is Invizius a public or private company?
Invizius is a private company.
What is the current stock price of Invizius?
Invizius is a private company, so its shares have no public market price. Caplight tracks Invizius's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Invizius worth (valuation)?
Valuation information for Invizius is not publicly available.
Can I buy Invizius stock?
Invizius shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Invizius's last funding round?
Invizius's most recent funding round was VC Round on September 23, 2024.
Who are the main investors in Invizius?
Key investors in Invizius include Innovate UK, Mercia Ventures, Mercia Asset Management, Mercia Ventures.
Will Invizius IPO soon?
No public IPO plans have been announced for Invizius.
How can I track Invizius secondary market activity?
Caplight tracks bids, offers, and trades in Invizius's shares on secondary markets.